trols. The increase in phospholipids in BAL fluid of cftr m1HGU/m1HGU mice resulted Background -Progressive pulmonary dysfrom an increased fraction of large agfunction is a characteristic symptom of gregates which exhibited normal surface cystic fibrosis (CF) and is associated with tension function. functional impairment and biochemical Conclusion -In cftr m1HGU/m1HGU mice suralterations of surfactant phospholipids in factant homeostasis is perturbed by an the airways. However, the fundamental increased phospholipid pool in the alveolar question of whether surfactant alterations compartment. in the CF lung are secondary to the pul- (Thorax 1997;52:723-730) monary damage or are present before initiation of chronic infection and inKeywords: cystic fibrosis, surfactant pool size, flammation has yet to be resolved in cftr m1HGU/m1HGU mouse.
body-independent defence functions of sur-         factant, 11 altered phospholipid homeostasis may consequently affect pulmonary integrity. Animals were anaesthetised with an intraperitoneal injection of 100 mg ketamine hydroTo investigate any such primary alterations in surfactant homoeostasis we analysed the chloride (Ketanest, WDT Corporation, Garbsen, Germany) and 4 mg xylocaine hydroconcentration of surfactant phospholipids and SP-A in lungs of cftr m1HGU/m1HGU mice. 12 13 We chloride (Rompun, Bayer AG, Leverkusen, Germany) per kg body weight prior to sacrifice. further investigated in this mouse model the composition of surfactant phospholipid classes This standard procedure was used since it does not cause respiratory depression during anas well as phosphatidylcholine molecular species and, finally, the surface tension function aesthesia. The trachea was cannulated with a small catheter, the abdomen opened, and the of lung surfactant in comparison with healthy controls. In cftr m1HGU/m1HGU mice a cftr gene animal bled by dissecting the abdominal aorta. The thorax was then opened, the lungs ventildefect was generated by insertional mutagenesis into exon 10 of the cftr gene 12 in which ated once with 1 ml of ambient air, and the lung perfused with 154 mM saline at room aberrant skipping results in the synthesis of 5-10% wild type transcript and therefore rel-temperature at a pressure of 15 cm H 2 O via the right ventricle. The lung was then flushed atively mild symptoms of cftr deficiency. 13 It was our aim to determine whether there was five times via the tracheal catheter with 1 ml 154 mM saline and the pooled bronchoalveolar any primary deviation in pulmonary phospholipids of cftr m1HGU/m1HGU mice in the absence lavage (BAL) fluid was centrifuged for 10 minutes at 150g and 4°C to remove cells. The total of chronic pulmonary infection. 5 recovery of BAL fluid was 4.5 ml and did not differ between the experimental groups. BAL fluid and lavaged lungs were frozen at −80°C until further analysis. Methods  Specific pathogen-free cftr m1HGU/m1HGU mice sup-  For phospholipid quantitation in cell-free BAL plied from Edinburgh 12 as well as Ztm:MF1, BALB/cZtm, C57/BL6Ztm, and C3H/HeZtm fluid two aliquots of 300 l were placed into phosphate-free glass tubes, the volumes mice were bred at our local animal house. cftr m1HGU/m1HGU mice originated from five differ-adjusted to 1 ml with 154 mM saline, and this material was extracted with chloroform/methent breeding lines. Mice were kept in a flexible film isolator under specified pathogen-free con-anol according to the method of Bligh and Dyer. 15 The chloroform extract was dried under ditions. The hygienic status was tested monthly according to Kunstyr 14 and the mice were free a stream of nitrogen and the glass tube directly used for phospholipid quantitation. To quantify from murine pathogens. The temperature within the isolator was maintained at 20-24°C phospholipids in subfractions of BAL fluid aliquots of P60000 and S60000 were extracted with 40-50% relative humidity. Animals were fed an irradiated (5 Mrad) standard diet (Al-with chloroform/methanol as outlined above.
Lavaged lungs were extracted according to tromin 1314) and autoclaved water (134°C, 50 minutes) was given ad libitum. Mice sub-Folch et al, 16 the extract adjusted to 10 ml with chloroform/methanol 9:1 (v/v) and two aliquots jected to analysis were 5-7 weeks old and the numbers of experiments were not based on any of 100 l used for phospholipid quantitation.
Phospholipid phosphorus was determined by pre-study power calculations. High performance liquid chromatography (HPLC) the method of Bartlett 17 after digesting the organic compounds at 190°C for 35 minutes grade solvents were supplied by Baker (Deventer, Holland). All other solvents and chem-in the presence of 500 l 70% perchloric acid (w/v) and 200 l 30% hydrogen peroxide (w/ icals were of analytical grade and from various commercial sources. v). The amount of phospholipid in total samples was calculated from phospholipid phosphorus in the measured sample aliquots and the original sample volume (BAL fluid, P60000, S60000) or extract volume (total lung extract).   For histological examination cftr m1HGU/m1HGU mice (n=6, 6-10 weeks old) and MF1 mice (n=6) were sacrificed by cervical dislocation    
The distribution of total phospholipid classes and bled by incision of the abdominal aorta. The thorax was opened and, after perfusing in lipid extracts was determined by normal phase HPLC as described previously. 18 In brief, the lung with 1 ml cold phosphate buffered saline via the right ventricle, the trachea was aliquots containing 80-100 nmol phospholipid dissolved in chloroform/methanol (1:4 v/v) cannulated with a small catheter. The lung was then filled with 1 ml OCT embedding medium were resolved isocratically on an aminopropyl silica column (Nucleosil NH 2 , 5 mm, Scham-(Miles Inc, Elkhart, Indiana, USA) diluted 1:4 with 4% buffered formalin and further beck, Germany) of 235 × 4.6 mm internal diameter. The mobile phase was delivered immersed in 4% buffered formalin for fixation. Paraffin-embedded sections (5 m) were pre-at a flow rate of 1 ml/min and comprised acetonitrile/methanol/water/methylphosphonic pared and stained with haematoxylin and eosin. Surfactant was prepared from cell-free BAL cies of phosphatidylcholine (PC) was determined as previously described by Postle. 19 fluid by centrifugation at 60 000g and 4°C for one hour. 22 The 60 000g supernatant (S60000) A PC fraction was isolated from the total lipid extract on a 100 mg Varian Bondelut NH 2 dis-was harvested and frozen at −80°C for further lipid analysis. The 60 000g pellet (P60000) was posable cartridge (Jones Chromatography, Hengoed, Mid Glamorgan, UK). PC molecular resuspended in 60 l 154 mM saline supplemented with 1.5 mM calcium chloride and species were then resolved on a Spherisorb ODS II column (Schambeck SFD, Bad the phospholipid concentration determined from an aliquot and then adjusted to the desired Honnef, Germany) of internal diameter 250 × 4.6 mm at 50°C using a mobile phase concentration for functional analysis (see below). of methanol/water (92.5:7.5 v/v) containing 40 mM choline chloride at a flow rate of 1 ml/ min. Eluted PC molecular species were quantified by post-column fluorescence derivative    For functional analysis P60000 was adjusted formation as outlined above. to 1.33 mol phospholipid/ml with 154 mM saline/1.5 mM calcium chloride. Equilibrium ( equil) and minimal ( min) surface tensions      - Total protein was determined according to the were then determined using a pulsating bubble surfactometer (Electronetics Co, Amherst, method of Lowry et al. 20 SP-A was determined by an ELISA technique using polyclonal anti-New York, USA). 23 Briefly, a bubble was created in a surfactant suspension at 37°C and human SP-A antibodies which cross-reacted with murine SP-A. 21 Briefly, polyclonal antiequil was determined as surface tension 10 seconds after formation of the bubble. The human antibodies were prepared in chickens and New Zealand rabbits by repeated injection bubble was then pulsated for five minutes at a frequency of 20 oscillations per min between of approximately 1 mg purified human SP-A in Freund's complete adjuvant. The chicken a minimal bubble radius of 0.4 mm and a maximal radius of 0.55 mm. The pressure and rabbit antisera were then used as the first and second antibodies in a capture ELISA. across the bubble was measured by a pressure transducer. equil and min were calculated The microtitre plates (Limbro, ICN Biomedicals Ltd, High Wycombe, Bucks, UK) using the LaPlace equation. 24 were coated with chicken anti-human SP-A IgY (10 g/ml in 35 mM Na 2 CO 3 , pH 9.6) at 4°C overnight and the non-specific binding   Data are expressed as means with 95% consites were blocked with TBS-NTC (50 mM Tris, 50 mM NaCl, 2 mM CaCl 2 , 0.05% (v/ fidence intervals (CI) in parentheses. Statistical analyses were performed by one factor analysis v) Tween-20, 0.05% (w/v) NaN 3 , pH 7.4) containing 1 mg/ml bovine serum albumin for of variance (ANOVA) and the two tailed Student's t test using commercial software (Graphone hour at 37°C. Purified human SP-A (10-1000 ng/ml) to be used as standards and Pad InStat Version 1.1, San Diego, USA).
Statistical values were corrected for multi-BAL fluid samples were duplicated in four serial dilutions in TBS-NTC buffer. The final group comparisons using the Bonferroni method and statistical values of regression coamounts of SP-A were calculated using these four dilutions. After extensive washes of the efficients were calculated using the same software. wells with TBS-NTC buffer, the samples and standards (100 l) were added to each well and incubated for three hours at 37°C. After a series of washes with buffer the plates were then Results   incubated with biotinylated rabbit anti-human IgG (50 g/ml, 100 l/well) for two hours at The morphology of cftr m1HGU/m1HGU mice showed a regular structure of lung tissue (fig 1) . No 37°C. Finally, streptavidin-alkaline phosphatase conjugate (Sigma Chemical Co. Ltd, Poole, signs of inflammation as leucocytic infiltration or interstitial oedema were found in any of the Dorset, UK) diluted 1:10000 in TBS-NTC containing 1 mg/ml BSA was added and al-animals examined. Comparison of the number and distribution of Clara cells and type II lowed to bind for one hour at room temperature. After washing the plates with TBS-alveolar epithelial cells revealed no detectable differences between MF1 and cftr m1HGU/m1HGU
NTC buffer, p-nitrophenyl phosphate (Sigma) was used as a substrate for the phosphatase mice. 
    -
In both controls and cftr m1HGU/m1HGU mice there were significant positive correlations between In BAL fluid from cftr m1HGU/m1HGU mice the amount of phospholipid was 1.02 (95% CI the amounts of phospholipid in BAL fluid or lavaged lung tissue and the body weight of the 0.89 to 1.16) mol/total BAL fluid but it was significantly lower in controls (table 1). In BAL animals ( fig 2) . We therefore corrected the amount of phospholipid in BAL fluid for the fluid from BALB/c, C57BL/6, and C3H/He mice the concentrations of phospholipid were individual body weights of mice. After such correction the amount of phospholipid in total 0.50 (0.42 to 0.57), 0.52 (0.40 to 0.64), and 0.45 (0.27 to 0.63) mol/total BAL fluid, re-BAL fluid from cftr m1HGU/m1HGU mice was 43.4 (39.0 to 47.9) nmol/total BAL fluid/g body spectively, and in BAL fluid from MF1 mice it was between the values of these controls and weight (table 1) were calculated between the total amount of phospholipids group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from were those of sphingomyelin (SPH) or phosphatidylethanolamine (PE) increased in either BAL fluid or lung tissue of cftr m1HGU/m1HGU mice. Because there were no differences in the phospholipid compositions of BALB/c, C57BL/6 and C3H/He mice, these data were combined and are shown as "other controls". Since the key molecule of surface tension function of lung surfactant is PC16:0/16:0, and since alterations in the concentrations of individual molecular species of PC are a more sensitive indicator of pulmonary surfactant alterations than the determination of PC fatty acids by gas chromatography, 19 we subsequently investigated these PC molecular species in both BAL fluid and lavaged lung tissue. The BAL fluid and lavaged lung tissue of cftr without major changes in cftr m1HGU/m1HGU mice compared with controls. The highly unsaturated PC species palmitoylarachidonoyl- Table 4 The relative concentration of active surfactant a 13 experiments from BALB/c (n=4), C57BL/6 (n=5), and C3H/He (n=4) mice.
isolated by differential ultracentrifugation at 60 000g (P60000) compared with the phospholipids in the supernatant (S60000) of the surfactant and important for its interactions with type II alveolar cells, phospholipids, bac-BAL fluid is shown in fig 3. In BAL fluid from cftr m1HGU/m1HGU mice the amount of phosteria and alveolar macrophages, was 259 (239 to 279) ng/total BAL fluid of cftr m1HGU/m1HGU pholipid in P60000 was significantly higher than in controls. To evaluate whether the surmice which was identical to the concentrations in BAL fluid of control mice (table 1). Due to face tension function of the P60000 was different from that of controls we measured the the increase in the concentration of phospholipids in the BAL fluid, the ratio of SP-A to phos-surface tension function of this material.
Equilibrium surface tension ( equil) after 10 pholipid was decreased by 33-45% from 0. (table 1) . respectively (table 4) . Dynamic measurement of minimal surface tension ( min) showed that P60000 from cftr m1HGU/m1HGU mice reached val-      ()  ues below 5 mN/m as quickly as surfactant from the control mice (table 4) .  Investigation of phospholipid compositional changes in BAL fluid and lung tissue of cftr m1HGU/m1HGU mice was in the first instance Discussion Cystic fibrosis is an inherited disease with a addressed by HPLC analysis of phospholipid classes. As shown in table 2 there were no defect in the CFTR gene resulting in the expression of a defective cAMP-dependent chlordifferences in the relative composition of phospholipid classes in BAL fluid and lung tissue ide channel. 1 2 Previous reports of impairment to the biophysical properties of airway seof cftr m1HGU/m1HGU and control mice. Importantly, the contributions of PC and phos-cretions, as well as lipid extracts of such secretions in patients with cystic fibrosis asphatidylglycerol (PG) were not decreased, nor group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from sociated with an altered phospholipid comSeveral mechanisms could lead to an accumulation of surfactant phospholipid in the position, have been attributed to the associated alveolar space. Decreased clearance of surchronic inflammatory processes. [1] [2] [3] [4] [5] The posfactant along the conductive airways due to sibility of a primary defect in surfactant prothe impaired bronchopulmonary clearance in cessing in cystic fibrosis has not previously been CFTR deficiency is unlikely to play a major considered. 1 2 25 However, recent RNA in situ role since this is typically a minor route for hybridisation studies have demonstrated that surfactant clearance. 27 Recent findings in isolthe CFTR gene is expressed in the lung ated cells from patients with cystic fibrosis, periphery in type II alveolar epithelial cells however, support the concept that a primary which produce both surfactant proteins and alteration of phospholipid metabolism 10 may phospholipids.
6 7 Moreover, an increased phoscontribute to this increased surfactant phospholipid turnover was described in isolated pholipid pool in the alveolus. In isolated fibrohuman fibroblasts and blood platelets from blasts and platelets from patients with cystic patients with cystic fibrosis.
10 Hence, lung surfibrosis phospholipid synthesis was increased, factant metabolism could be affected by the but such cells do not secrete major amounts of basic defect of cystic fibrosis prior to and inphospholipid. However, despite the tempting dependent from the chronic inflammatory explanations outlined above, other exprocesses in the lungs. 1 2 25 To address this planations for an increase in surfactant phosissue we employed the cftr m1HGU/m1HGU mouse 12 pholipids in the alveolar space should be as an animal model to study aspects of lung mentioned. The cftr gene transcript regulates surfactant metabolism in cystic fibrosis the cAMP-dependent Cl − current and thereby prior to chronic pulmonary infection. The the transport of other ions and of water through cftr m1HGU/m1HGU mouse is a useful model for cells. 2 Cftr expression in type II alveolar epihuman cystic fibrosis because, unlike the abthelial cells 6 7 could indirectly alter the homeosolute "null" mutant mouse, this model shows stasis of the watery alveolar hypophase and of normal growth rate and good long term surcAMP, thereby influencing surfactant phosvival. This is due to the "leaky" nature of the pholipid homeostasis. mutation which results in 5-10% residual wild
The alterations in cftr m1HGU/m1HGU mice detype after expression. The cftr m1HGU/m1HGU mouse scribed in this study are different from those is thus analogous to patients with cystic fibrosis previously described in chronically infected aircarrying CFTR mutations which retain partial ways of human subjects. While in studies on CFTR function.
airway secretions from patients with cystic fibOur data show, for the first time, that BAL rosis alterations in phospholipid classes, fatty fluid concentrations of surfactant phospholipid acid composition of phospholipids, and bioas an index for the intra-alveolar surfactant physical properties (adsorption velocity) were pool are primarily increased by about 60% in described, 25 we did not detect such changes in a CFTR-deficient organism compared with all BAL fluid from cftr m1HGU/m1HGU mice without other tested control strains, whereas the infection. Similarly, no impairment of surface amount of phospholipid in lung tissue is not tension function of the surfactant isolated from altered. While we could not demonstrate bio-the BAL fluid of cftr m1HGU/m1HGU mice was dechemical alterations of alveolar phospholipid tected. We therefore conclude that such almaterial, the quantitative changes in alveolar terations are due to chronic inflammation and surfactant phospholipids were due to an in-leucocyte infiltration of cystic fibrosis lungs, crease in material which could be pelleted by secondary to colonisation with opportunistic ultracentrifugation at 60 000g (P60000) as pre-bacteria. Our data support the concept that viously described in the mouse by other in-any alteration in the phospholipid composition vestigators. 22 In that study it was demonstrated is due to chronic infection and inflammation that the P60000 consisted of large surfactant rather than an effect of CFTR mutations. aggregates, while so-called small surfactant agWhile phospholipids were increased in the gregates remained in the 60000g supernatant BAL fluid, the amount of SP-A remained un-(S60000). Moreover, it was demonstrated that changed. This unexpected finding is in agree-P60000 consisted of surface active material ment with a recent study by Doyle et al who while S60000 contained only inactive material. showed that phospholipid and SP-A secretion Our functional data are consistent with these into the alveolus are independently regulated. 26 observations since P60000 present in BAL fluid While the mechanisms of such changes in from both cftr m1HGU/m1HGU and control mice was cftr m1HGU/m1HGU mice are still uncertain and await highly surface active. It was suggested that, further investigation, the potential conduring the dynamic processing of surfactant sequences for pulmonary defence of an infrom its secretion to its re-uptake into type II creased amount of phospholipid and a pneumocytes, P60000 represents freshly se-decreased ratio of SP-A to phospholipid are creted surface active material while S60000 more obvious. Surfactant contributes to pulrepresents inactivated "older" surfactant which monary integrity as a first line of defence.
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shows poor surface tension function. 22 26 It is Phospholipid inhibits the activity of SP-A to therefore reasonable to attribute the increased opsonise bacteria and depresses the respiratory alveolar surfactant pool size in cftr m1HGU/m1HGU burst of alveolar macrophages upon mice to an increase in newly secreted active challenge. 11 28 Increased phospholipid consurfactant ("large aggregates") rather than an centrations together with a decreased SP-A to accumulation of inactivated older surfactant phospholipid ratio in cftr m1HGU/m1HGU mice, and possibly in patients with cystic fibrosis, may ("small aggregates") 22 in the alveolar space. 
